Biovie Inc.

Biovie Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Focusing on Finding Solutions for Healthier Brain, Memory, and Movement. Our neurology strategy is centered at what we understand to be the nexus of biochemistry, cellular energetics, and neuroprotection, enabling us to explore the potential of our pipeline molecules to decrease inflammation, enhance glucose utilization, protect neurons, and facilitate energy transfer within the central nervous system, ultimately leading to improvements in memory and movement, and a healthier brain. Our lead Neuroscience molecule (NE3107) is currently being investigated in human clinical studies to assess its hypothesized impact on both Alzheimer’s and Parkinson’s. Exploring the possibilities of improved outcomes, fewer medical burdens, and more time at home. In our cirrhosis studies, we are working to learn if our exploratory technology can help individuals who have been diagnosed with cirrhosis-related ascites (fluid that builds up inside the abdomen) to be more comfortable, to require fewer or less frequent medical procedures to drain ascites fluid, and to see if the treatment can help people with ascites to live outside of the hospital for longer periods of time. BioVie is currently investigating BIV-201, a novel formulation of terlipressin, in human clinical trials. In BioVie’s studies of BIV-201, the exploratory medication is provided as a continuous infusion formulation delivered by a small, portable pump that the user can wear while engaging in typical tasks and activities at home. For more information about BioVie and our current studies, please visit our website https://bioviepharma.com/
Looking for a particular Biovie Inc. employee's phone or email?

Biovie Inc. Questions

News

BioVie Inc.’s NE3107 Study: A New Hope for Early Parkinson’s Treatment - TipRanks

BioVie Inc.’s NE3107 Study: A New Hope for Early Parkinson’s Treatment TipRanks

BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewswire

BioVie Inc. Announces Pricing of $12 Million Public Offering GlobeNewswire

Is BioVie Inc. stock a dividend growth opportunity - July 2025 Analyst Calls & High Accuracy Swing Trade Signals - Trung tâm Dự báo KTTV quốc gia

Is BioVie Inc. stock a dividend growth opportunity - July 2025 Analyst Calls & High Accuracy Swing Trade Signals Trung tâm Dự báo KTTV quốc gia

BioVie to Host Live Investor Webinar and Q&A on Oct. 8 - GlobeNewswire

BioVie to Host Live Investor Webinar and Q&A on Oct. 8 GlobeNewswire

BioVie Secures $12M Financing: Units at $2.00 Include 5-Year Warrants for Drug Development Pipeline - Stock Titan

BioVie Secures $12M Financing: Units at $2.00 Include 5-Year Warrants for Drug Development Pipeline Stock Titan

BioVie Inc. (BIVI) reports earnings - qz.com

BioVie Inc. (BIVI) reports earnings qz.com

BioVie Highlighted ADDRESS-LC Phase 2 Trial Design - GlobeNewswire

BioVie Highlighted ADDRESS-LC Phase 2 Trial Design GlobeNewswire

BioVie Inc. Appoints Dr. Amy S. Chappell and Kameel D. Farag to Board of Directors - Quiver Quantitative

BioVie Inc. Appoints Dr. Amy S. Chappell and Kameel D. Farag to Board of Directors Quiver Quantitative

BioVie Unveils Corporate Advisory Board Featuring Neuralink - GlobeNewswire

BioVie Unveils Corporate Advisory Board Featuring Neuralink GlobeNewswire

BioVie Inc. Announces Pricing of Public Offering - Yahoo Finance

BioVie Inc. Announces Pricing of Public Offering Yahoo Finance

How BioVie Inc. stock trades during market volatility - July 2025 Selloffs & Expert Curated Trade Setup Alerts - Trung tâm Dự báo KTTV quốc gia

How BioVie Inc. stock trades during market volatility - July 2025 Selloffs & Expert Curated Trade Setup Alerts Trung tâm Dự báo KTTV quốc gia

BioVie Highlights Patient-Centric Design of SUNRISE-PD - GlobeNewswire

BioVie Highlights Patient-Centric Design of SUNRISE-PD GlobeNewswire

BioVie Inc. Presents Promising Phase 3 Study Results for Bezisterim in Alzheimer’s Disease at WCAG-2025 - Quiver Quantitative

BioVie Inc. Presents Promising Phase 3 Study Results for Bezisterim in Alzheimer’s Disease at WCAG-2025 Quiver Quantitative

BioVie to Present Rationale and Design of Phase 2 - GlobeNewswire

BioVie to Present Rationale and Design of Phase 2 GlobeNewswire

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial - GlobeNewswire

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial GlobeNewswire

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled - GlobeNewswire

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled GlobeNewswire

BioVie Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson’s Disease - GlobeNewswire

BioVie Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson’s Disease GlobeNewswire

BioVie Announces Pipeline Update and Near-Term Clinical Priorities - GlobeNewswire

BioVie Announces Pipeline Update and Near-Term Clinical Priorities GlobeNewswire

Clinical-Stage Biotech BioVie Secures $12M Financing: Key Details of Stock and Warrant Offering Revealed - Stock Titan

Clinical-Stage Biotech BioVie Secures $12M Financing: Key Details of Stock and Warrant Offering Revealed Stock Titan

BioVie Inc.’s NE3107: A Promising Study for Long COVID Relief - TipRanks

BioVie Inc.’s NE3107: A Promising Study for Long COVID Relief TipRanks

Is BioVie Inc. stock a safe haven asset - Profit Target & Low Risk Investment Opportunities - Trung tâm Dự báo KTTV quốc gia

Is BioVie Inc. stock a safe haven asset - Profit Target & Low Risk Investment Opportunities Trung tâm Dự báo KTTV quốc gia

Individual investors invested in BioVie Inc. (NASDAQ:BIVI) copped the brunt of last week's US$55m market cap decline - Yahoo Finance

Individual investors invested in BioVie Inc. (NASDAQ:BIVI) copped the brunt of last week's US$55m market cap decline Yahoo Finance

Is BioVie Inc. stock affected by interest rate hikes - Trade Volume Summary & Weekly Sector Rotation Insights - Trung tâm Dự báo KTTV quốc gia

Is BioVie Inc. stock affected by interest rate hikes - Trade Volume Summary & Weekly Sector Rotation Insights Trung tâm Dự báo KTTV quốc gia

BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire

Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - The Globe and Mail

Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights The Globe and Mail

Is BioVie Inc. stock affected by interest rate hikes - Market Performance Report & Low Drawdown Investment Ideas - Trung tâm Dự báo KTTV quốc gia

Is BioVie Inc. stock affected by interest rate hikes - Market Performance Report & Low Drawdown Investment Ideas Trung tâm Dự báo KTTV quốc gia

BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating GlobeNewswire

BioVie Inc. Announces Reverse Stock Split - Stock Titan

BioVie Inc. Announces Reverse Stock Split Stock Titan

Is BioVie Inc. stock a safe haven asset - 2025 Year in Review & Safe Entry Momentum Stock Tips - Fundação Cultural do Pará

Is BioVie Inc. stock a safe haven asset - 2025 Year in Review & Safe Entry Momentum Stock Tips Fundação Cultural do Pará

BioVie Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMedix - GlobeNewswire

BioVie Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMedix GlobeNewswire

BioVie Inc: A Catalyst-Rich Year Ahead (NASDAQ:BIVI) - Seeking Alpha

BioVie Inc: A Catalyst-Rich Year Ahead (NASDAQ:BIVI) Seeking Alpha

BIVI Stock Quote Price and Forecast - CNN

BIVI Stock Quote Price and Forecast CNN

BioVie Inc.: Is it a Rising Star or a Passing Trend? - timothysykes.com

BioVie Inc.: Is it a Rising Star or a Passing Trend? timothysykes.com

Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - The Joplin Globe

Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights The Joplin Globe

SEC Accuses Investment Advisor of $1.4M Pump-and-Dump Scheme Involving BioVie Inc. - USA Herald

SEC Accuses Investment Advisor of $1.4M Pump-and-Dump Scheme Involving BioVie Inc. USA Herald

BioVie Acquires Biopharma Assets from Privately Held NeurMedix - GlobeNewswire

BioVie Acquires Biopharma Assets from Privately Held NeurMedix GlobeNewswire

BioVie Inc.’s Recent Surge: Should Investors Brace for More Surprises? - timothysykes.com

BioVie Inc.’s Recent Surge: Should Investors Brace for More Surprises? timothysykes.com

BioVie Announces Closing of Public Offering of Common Stock - GlobeNewswire

BioVie Announces Closing of Public Offering of Common Stock GlobeNewswire

Top Biovie Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant